Petri Dish: Late-stage cancer trial halt; Dyne names CFO
A Waltham company pulled the plug on a Phase 3 cancer trial, while a different Waltham company continued its leadership ...
China.org.cn6h
Pharmaceutical multinationals double down on China's biotech innovations
Multinational pharmaceutical firms, particularly U.S. giants, are increasingly recognizing China's burgeoning innovative drug sector as a strategic goldmine to bolster their global competitiveness.
A heart-shaped note was found in socks bound for Luigi Mangione
Someone tucked a heart-shaped note of encouragement into a pair of socks packed for Luigi Mangione to wear to a court ...
Ex-Intel CEO Gelsinger joins venture capital firm Playground Global
Pat Gelsinger, the former CEO of Intel , on Wednesday joined venture capital firm Playground Global as a general partner and ...
Crispr Therapeutics Operating Chief Julianne Bruno to Step Down
Crispr Therapeutics said Chief Operating Officer Julianne Bruno would depart the company to pursue other opportunities, effective April 11. Bruno joined the gene-editing company in 2019 and stepped ...